|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
70,650,000 |
Market
Cap: |
3.28(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$38.62 - $89.12 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile CRISPR Therapeutics is a gene editing company focused on the development of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) based therapeutics. CRISPR/Cas9 is a technology for gene editing, the process of altering specific sequences of genomic DNA. Co. is developing several gene-edited allogeneic cell therapy programs. Co.'s main product candidate, CTX001, is an investigational ex vivo CRISPR gene-edited therapy that is being evaluated for patients suffering from transfusion-dependent beta thalassemia or severe sickle cell disease in which a patient's hematopoietic stem cells are engineered to produce fetal hemoglobin in red blood cells.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
22,948 |
163,087 |
338,087 |
Total Sell Value |
$0 |
$1,362,031 |
$11,023,312 |
$20,394,162 |
Total People Sold |
0 |
2 |
4 |
4 |
Total Sell Transactions |
0 |
2 |
13 |
20 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Bruno Julianne |
Chief Operating Officer |
|
2024-05-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
7,088 |
|
-18% |
|
Bruno Julianne |
Chief Operating Officer |
|
2024-05-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,111 |
|
-18% |
|
Kulkarni Samarth |
Chief Executive Officer |
|
2024-04-15 |
4 |
AS |
$59.88 |
$1,173,232 |
D/D |
(19,582) |
208,122 |
|
-16% |
|
Kulkarni Samarth |
Chief Executive Officer |
|
2024-04-15 |
4 |
OE |
$19.12 |
$374,408 |
D/D |
19,582 |
227,704 |
|
- |
|
Kulkarni Samarth |
Chief Executive Officer |
|
2024-03-15 |
4 |
AS |
$71.97 |
$1,449,628 |
D/D |
(20,000) |
208,122 |
|
-21% |
|
Kulkarni Samarth |
Chief Executive Officer |
|
2024-03-15 |
4 |
OE |
$19.12 |
$382,400 |
D/D |
20,000 |
228,122 |
|
- |
|
Prasad Raju |
Chief Financial Officer |
|
2024-03-15 |
4 |
S |
$72.69 |
$256,160 |
D/D |
(3,524) |
6,476 |
|
21% |
|
Prasad Raju |
Chief Financial Officer |
|
2024-03-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
|
- |
|
Kasinger James R. |
General Counsel and Secretary |
|
2024-03-12 |
4 |
S |
$74.44 |
$85,308 |
D/D |
(1,146) |
61,174 |
|
24% |
|
Kulkarni Samarth |
Chief Executive Officer |
|
2024-03-12 |
4 |
S |
$74.44 |
$341,159 |
D/D |
(4,583) |
208,122 |
|
24% |
|
Kasinger James R. |
General Counsel and Secretary |
|
2024-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,250 |
62,320 |
|
- |
|
Kasinger James R. |
General Counsel and Secretary |
|
2024-03-11 |
4 |
S |
$78.26 |
$219,206 |
D/D |
(2,801) |
60,070 |
|
27% |
|
Kulkarni Samarth |
Chief Executive Officer |
|
2024-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,000 |
212,705 |
|
- |
|
Kulkarni Samarth |
Chief Executive Officer |
|
2024-03-11 |
4 |
S |
$78.26 |
$767,105 |
D/D |
(9,802) |
203,705 |
|
27% |
|
Kasinger James R. |
General Counsel and Secretary |
|
2024-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,500 |
62,871 |
|
- |
|
Kulkarni Samarth |
Chief Executive Officer |
|
2024-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,250 |
213,507 |
|
- |
|
George Simeon |
|
|
2024-02-27 |
4 |
A |
$71.50 |
$74,999,997 |
I/I |
1,048,951 |
769,196 |
|
- |
|
Kasinger James R. |
General Counsel and Secretary |
|
2024-02-20 |
4 |
S |
$79.67 |
$152,409 |
D/D |
(1,913) |
57,371 |
|
31% |
|
Kulkarni Samarth |
Chief Executive Officer |
|
2024-02-20 |
4 |
S |
$79.67 |
$507,498 |
D/D |
(6,370) |
194,257 |
|
31% |
|
Kasinger James R. |
General Counsel and Secretary |
|
2024-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,825 |
59,284 |
|
- |
|
Kulkarni Samarth |
Chief Executive Officer |
|
2024-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,250 |
200,627 |
|
- |
|
Kulkarni Samarth |
Chief Executive Officer |
|
2024-02-15 |
4 |
AS |
$79.94 |
$1,607,177 |
D/D |
(20,000) |
187,377 |
|
-34% |
|
Kulkarni Samarth |
Chief Executive Officer |
|
2024-02-15 |
4 |
OE |
$19.12 |
$382,400 |
D/D |
20,000 |
207,377 |
|
- |
|
Kulkarni Samarth |
Chief Executive Officer |
|
2024-01-29 |
4 |
AS |
$60.50 |
$3,025,573 |
D/D |
(50,000) |
187,377 |
|
-12% |
|
Kulkarni Samarth |
Chief Executive Officer |
|
2024-01-29 |
4 |
OE |
$19.12 |
$956,000 |
D/D |
50,000 |
237,377 |
|
- |
|
485 Records found
|
|
Page 1 of 20 |
|
|